ad image

Roundtable

1 / 4
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Drug Approvals

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Pharma's Almanac

PAO-03-25-RT-01Mar 26, 2025
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
RNA

What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?

Pharma's Almanac

PAO-03-25-RT-02Mar 26, 2025
Is AI truly transforming drug development, or are we still navigating through the hype?
AI

Is AI truly transforming drug development, or are we still navigating through the hype?

Pharma's Almanac

PAO-02-25-RT-01Feb 26, 2025
What strategies are ensuring supply chain resilience in a post-COVID world?
Supply Chain

What strategies are ensuring supply chain resilience in a post-COVID world?

Pharma's Almanac

PAO-02-25-RT-02Feb 26, 2025
How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?
Sustainability

How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?

Pharma's Almanac

PAO-01-25-RT-02Jan 31, 2025
How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?
Personalized

How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?

Pharma's Almanac

PAO-01-25-RT-01Jan 31, 2025
How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?
Innovation

How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?

Pharma's Almanac

PAO-11-24-RT-02Oct 28, 2024
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
BIOSECURE Act

Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?

Pharma's Almanac

PAO-11-24-RT-01Oct 28, 2024
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Changing Roles

How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?

Pharma's Almanac

PAO-08-24-RT-01Aug 07, 2024
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Global Access

How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?

Pharma's Almanac

PAO-08-24-RT-02Aug 07, 2024
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

PAO-06-24-RT-02Jun 24, 2024
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

PAO-06-24-RT-01Jun 24, 2024
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

PAO-03-24-CL-03Mar 08, 2024
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

PAO-03-24-CL-02Mar 08, 2024
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

PAO-12-23-RT-02Dec 15, 2023
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

PAO-12-23-RT-01Dec 14, 2023
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

PAO-09-23-RT-01Sep 15, 2023
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

PAO-09-23-RT-02Sep 15, 2023
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

PAO-07-23-RT-01Jul 21, 2023
How is an increased focus on patient-centric concerns influencing the way that you work?
Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

PAO-07-23-RT-02Jul 21, 2023
1 / 4